Increased LEF1 expression and decreased notch2 expression are strong predictors of poor outcomes in colorectal cancer patients

Disease Markers

Volumn 35, Issue 5, 2013, Pages 395-405

  Wang, Wen Juan ^a   Yao, Yu ^a   Jiang, Li Li ^a   Hu, Ting Hua ^a   Ma, Jie Qun ^a   Ruan, Zhi Ping ^a   Tian, Tao ^a   Guo, Hui ^a   Wang, Shu Hong ^a   Nan, Ke Jun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; NOTCH2 RECEPTOR;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENETIC ASSOCIATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, NOTCH2; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84890335405     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2013/983981     Document Type: Article

References (44)

1. T. Gansler, P. A. Ganz,M.Grant et al., "Sixty years of ca: a cancer journal for clinicians," CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 345-350, 2010.
2. A. Jemal, R. Siegel, J. Xu, and E.Ward, "Cancer statistics, 2010," CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277-300, 2010.
3. T. Lei, W.-Q. Chen, S.-W. Zhang et al., "Prevalence trend of colorectal cancer in 10 cities and counties in China from1988 to 2002," Zhonghua Zhong Liu Za Zhi, vol. 31, no. 6, pp. 428-433, 2009.
4. P. Andreu, S. Colnot, C. Godard et al., "Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in themouse intestine," Development, vol. 132, no.6,pp. 1443-1451, 2005.
5. S. Fre, M. Huyghe, P.Mourikis, S. Robine, D. Louvard, and S. Artavanis-Tsakonas, "Notch signals control the fate of immature progenitor cells in the intestine," Nature, vol. 435, no. 7044, pp. 964-968, 2005.
6. S. Fre, S. K. Pallavi, M. Huyghe et al., "Notch andWnt signals cooperatively control cell proliferation and tumorigenesis in the intestine," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 15, pp. 6309-6314, 2009.
7. J. H. van Es, M. E. vanGijn,O. Riccio et al., "Notch/γ- secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells," Nature, vol. 435, no. 7044, pp. 959-963, 2005.
8. J. H. Van Es and H. Clevers, "Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease," Trends in Molecular Medicine, vol. 11, no. 11, pp. 496-502, 2005.
9. M. Shitashige, S. Hirohashi, and T. Yamada, "Wnt signaling inside the nucleus," Cancer Science, vol. 99, no. 4, pp. 631-637, 2008.
10. T.-W. Li, J.-H. Ting,N. N. Yokoyama, A. Bernstein,M. Van De Wetering, andM. L.Waterman, "Wnt activation and alternative promoter repression of LEF1 in colon cancer," Molecular and Cellular Biology, vol. 26, no. 14, pp. 5284-5299, 2006.
11. D. N. Shelton, H. Fornalik, T. Neff et al., "The role of LEF1 in endometrial gland formation and carcinogenesis," PlosOne, vol. 7, Article ID e40312, 2012.
12. L. E. Valdivia, R. M. Young, T. A. Hawkins et al., "Lef1-dependent Wnt/β-catenin signalling drives the proliferative engine that maintains tissue homeostasis during lateral line development," Development, vol. 138, no. 18, pp. 3931-3941, 2011.
13. K. H.Metzeler, B. Heilmeier, K. E. Edmaier et al., "High expression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in cytogenetically normal acute myeloid leukemia," Blood, vol. 120, pp. 2118-2126, 2012.
14. L.H.Hoeppner, F. J. Secreto, D. F. Razidlo,T. J.Whitney, and J. J. Westendorf, "Lef1δN binds β-catenin and increases osteoblast activity and trabecular bone mass," Journal of Biological Chemistry, vol. 286, no. 13, pp. 10950-10959, 2011.
15. L.-K. Phng, M. Potente, J. D. Leslie et al., "Nrarp coordinates endothelialNotch andWnt signaling to control vessel density in angiogenesis," Developmental Cell, vol. 16,no. 1, pp. 70-82, 2009.
16. T.K.Noah andN. F. Shroyer, "Notch in the intestine: regulation of homeostasis and pathogenesis," Annual Review of Physiology, vol. 75, pp. 263-288, 2013.
17. J.-L. Li, R. C. Sainson, C. E. Oon et al., "DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo," Cancer Research, vol. 71, no. 18, pp. 6073-6083, 2011.
18. G. P. Dotto, "Notch tumor suppressor function," Oncogene, vol. 27, no. 38, pp. 5115-5123, 2008.
19. A. Pannuti, K. Foreman, P. Rizzo et al., "Targeting Notch to target cancer stem cells," Clinical Cancer Research, vol. 16,no. 12, pp. 3141-3152, 2010.
20. T. Sasaki, H. Suzuki, K. Yagi et al., "Lymphoid enhancer factor 1makes cells resistant to transforming growth factor β-induced repression of c-myc," Cancer Research, vol. 63, no. 4, pp. 801-806, 2003.
21. D. Chu, J. Zheng, W. Wang et al., "Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status," Annals of SurgicalOncology, vol. 16,no. 12,pp. 3259-3266, 2009.
22. X. Liu, S.Wang, X. Xia et al., "Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer," Plos One, vol. 7, Article IDe52348, 2012.
23. T. Tian, K.-J.Nan, S.-H.Wang et al., "PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and-independent mechanisms in HepG2 cells," Carcinogenesis, vol. 31, no. 7, pp. 1211-1219, 2010.
24. M. Barbareschi, P. Maisonneuve, D. Aldovini et al., "High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis," Cancer, vol. 98, no. 3, pp. 474-483, 2003.
25. X. Liu, H. Zhang, L. Lai et al., "Ribonucleotide reductase small subunitM2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers," Clinical Science, vol. 124, no. 9, pp. 567-578, 2013.
26. W.Weichert, A. Roske, V. Gekeler et al., "Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis," The Lancet Oncology, vol. 9, no. 2, pp. 139-148, 2008.
27. L. Kriegl, D. Horst, J. A. Reiche, J. Engel, T. Kirchner, and A. Jung, "LEF-1 and TCF4 expression correlate inversely with survival incolorectal cancer," Journal of Translational Medicine, vol. 8, article 123, 2010.
28. D. Chu, Z. Zhang, Y. Zhou et al., "Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer," Annals of Oncology, vol. 22, no. 11, pp. 2440-2447, 2011.
29. A.-Y. Lin, M.-S. Chua, Y.-L. Choi et al., "Comparative profiling of primary colorectal carcinomas and livermetastases identifies LEF1 as a prognostic biomarker," PLoS One, vol. 6, no. 2,Article ID e16636, 2011.
30. K. Giese, A. Amsterdam, and R. Grosschedl, "DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1," Genes and Development, vol. 5, no. 12, pp. 2567-2578, 1991.
31. A. Milatovich, A. Travis, R. Grosschedl, and U. Francke, "Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf," Genomics, vol. 11, no. 4, pp. 1040-1048, 1991.
32. K. Hovanes, T.-W. Li, J. E. Munguia et al., "β-Cateninsensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer,"NatureGenetics, vol. 28,no. 1, pp. 53-57, 2001.
33. T. Reya and H. Clevers, "Wnt signalling in stem cells and cancer," Nature, vol. 434, no. 7035, pp. 843-850, 2005.
34. R. T. Moon, A. D. Kohn, G. V. De Ferrari, and A. Kaykas, "WNT and β-catenin signalling: diseases and therapies," Nature Reviews Genetics, vol. 5, no. 9, pp. 691-701, 2004.
35. A. Apelqvist, H. Li, L. Sommer et al., "Notch signalling controls pancreatic cell differentiation," Nature, vol. 400, no. 6747, pp. 877-881, 1999.
36. S. Miyamoto and D.W. Rosenberg, "Role of Notch signaling in colon homeostasis and carcinogenesis," Cancer Science, vol. 102, no. 11, pp. 1938-1942, 2011.
37. S.-Y. Lee, K. Kumano, K. Nakazaki et al., "Gain-of-function mutations and copy number increases ofNotch2 in diffuse large B-cell lymphoma," Cancer Science, vol. 100, no. 5, pp. 920-926, 2009.
38. C. F. O'Neill, S. Urs, C. Cinelli et al., "Notch2 signaling induces apoptosis and inhibits humanMDA-MB-231 xenograft growth," American Journal of Pathology, vol. 171, no. 3, pp. 1023-1036, 2007.
39. C. Parr, G. Watkins, andW.-G. Jiang, "The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer," International Journal ofMolecularMedicine, vol. 14, no. 5, pp. 779-786, 2004.
40. J. Ungerback, N. Elander, J. Grunberg, M. Sigvardsson, and P. Soderkvist, "The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells," PLoS One, vol. 6, no. 3,Article ID e17957, 2011.
41. F. E. Bertrand, C. W. Angus, W. J. Partis, and G. Sigounas, "Developmental pathways in colon cancer: crosstalk between WNT, BMP,Hedgehog and Notch," Cell Cycle, vol. 11, no. 23, pp. 4344-4351, 2012.
42. C. Spaulding, E. J. Reschly, D. E. Zagort et al., "Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas," Blood, vol. 110, no. 7, pp. 2650-2658, 2007.
43. X. Fan, I. Mikolaenko, I. Elhassan et al., "Notch1 and Notch2 have opposite effects on embryonal brain tumor growth," Cancer Research, vol. 64, no. 21, pp. 7787-7793, 2004.
44. S.-H. Wang, K.-J. Nan, Y.-C. Wang, W.-J. Wang, and T. Tian, "The balance between two isoforms of LEF-1 regulates colon carcinoma growth," BMC Gastroenterol, vol. 12, article 53, 2012.